胸腺肽肠溶片联合干扰素治疗慢性乙型肝炎的临床研究被引量：3

暂未订购

导出

作者李顺良刘生水

机构地区陕西省商洛市中心医院传染科

出处《中国药物与临床》 CAS 2006年第5期390-391,共2页 Chinese Remedies & Clinics

关键词慢性乙型肝炎胸腺肽肠溶片干扰素治疗联合重组临床研究乙型肝炎病毒(HBV) 抗病毒药物肝脏功能恢复临床治疗效果干扰素Α

分类号 R512.62 [医药卫生—内科学] R954 [医药卫生—药学]

引文网络
相关文献

参考文献7

1成军,李莉.抗乙型肝炎病毒联合治疗方案的研究进展[J].中华传染病杂志,2003,21(2):157-160. 被引量：22
2郑红俊,冯育林.α-2a干扰素联合胸腺肽治疗慢性乙型肝炎32例疗效观察[J].传染病信息,2002,15(2):83-83. 被引量：4
3Jing You Lin Zhuang Bao Zhang Tang Wei Bo Yang Su Ying Ding Wu Li Rong Xue Wu Hong Li Zhang Yan Mei Zhang Shao Ming Yan Lu Zhang ~1Department of Infectious Diseases,The First Affiliated Hospital of Kunming Medical College,Kunming 650032,Yunnan Province,China ~2Departrnent of Hepatology,Kunming Third Municipal People’s Hospital,Kunming 650041,Yunnan Province,China.A randomized controlled clinical trial on the treatment of Thymosin-a1 versus interferon-α in patients with hepatitis B[J].World Journal of Gastroenterology,2001,7(3):411-414. 被引量：47
4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量：14017
5吴在耕.慢性乙型肝炎的治疗现状[J].现代诊断与治疗,2001,12(2):119-120. 被引量：2
6俞海俐,施光峰.乙型肝炎的慢性化和慢性乙型肝炎的免疫学治疗[J].中华传染病杂志,2004,22(2):142-144. 被引量：18
7孙家华.国产α-2b干扰素治疗慢性乙型肝炎的临床疗效观察[J].天津医药,2000,28(5):309-310. 被引量：1

二级参考文献39

1闻玉梅.乙型肝炎治疗性疫苗的研究与应用[J].中华传染病杂志,1996,14(3):159-161. 被引量：19
2刘树林,杨悦,赵振国,吴玉环.干扰素联合白细胞介素－2治疗慢性乙型肝炎30例疗效观察[J].中华传染病杂志,1996,14(2):121-122. 被引量：16
3李永华,谭林,孙成斋,张金良,李丽军,谢法训,秦绍明.乙肝导向干扰素治疗慢性乙型肝炎疗效观察[J].中国实用内科杂志,1997,17(3):145-146. 被引量：6
4邵风珍刘秀华等.干扰素联合阿昔洛韦治疗慢性乙型肝炎[J].中华肝脏病杂志,1999,7(1):62-62.
5Hadziyannis S, Alexopoulou A, Papakonstantinou A, et al. Interferon treatment with or without oral ganeielovir in HBeAg-negative chronic hepatitis B: a randomized study. J Viral Hepat,2000,7 : 235-240.
6Johnson MA, Jenkins JM, Bye C. A study of the pharmacokinetic interaction between lamivudine and alpha interferon. Eur J Clin Pharmacol, 2000,56 : 289-292.
7Korba BE, Cote P, Hornbuckle W, et al. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks. Antivir Ther,2000,5 : 95-104.
8Mutimer D, Naoumov N, Honkoop P, et al. Combination alphainterferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study. J Hepatol,1998, 28:923-929.
9Schalm SW, Heatheote J, Cianciara J, et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut, 2000, 46: 562-568.
10Mutimer D, Dowling D, Cane P, et al. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection. Antivir Ther, 2000, 5:273-277.